Viral vector vaccine development and application during the COVID-19 pandemic
S Deng, H Liang, P Chen, Y Li, Z Li, S Fan, K Wu, X Li… - Microorganisms, 2022 - mdpi.com
With the accumulation of mutations in SARS-CoV-2 and the continuous emergence of new
variants, the importance of developing safer and effective vaccines has become more …
variants, the importance of developing safer and effective vaccines has become more …
Tracking the COVID-19 vaccines: The global landscape
ABSTRACT COVID-19, a respiratory infectious disease, occurs due to Severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …
Replicating viral vector-based vaccines for COVID-19: potential avenue in vaccination arena
The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
Advances in the design and development of SARS-CoV-2 vaccines
XL Peng, JSY Cheng, HL Gong, MD Yuan… - Military Medical …, 2021 - Springer
Since the end of 2019, coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA …
COVID-19 vaccines: an overview of different platforms
D Kudlay, A Svistunov - Bioengineering, 2022 - mdpi.com
Vaccination is one of the key strategies to stop the COVID-19 pandemic. This review aims to
evaluate the current state of vaccine development and to determine the issues that merit …
evaluate the current state of vaccine development and to determine the issues that merit …
COVID-19 pandemic and vaccines update on challenges and resolutions
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
Classical and next-generation vaccine platforms to SARS-CoV-2: biotechnological strategies and genomic variants
RSQ Simões, D Rodríguez-Lázaro - International Journal of …, 2022 - mdpi.com
Several coronaviruses (CoVs) have been identified as human pathogens, including the α-
CoVs strains HCoV-229E and HCoV-NL63 and the β-CoVs strains HCoV-HKU1 and HCoV …
CoVs strains HCoV-229E and HCoV-NL63 and the β-CoVs strains HCoV-HKU1 and HCoV …
Counting on COVID-19 vaccine: insights into the current strategies, progress and future challenges
R Kandimalla, P Chakraborty, J Vallamkondu… - Biomedicines, 2021 - mdpi.com
The emergence of a novel coronavirus viz., severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …
Adenoviral vector-based vaccine platform for COVID-19: Current status
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …
21st century, claiming millions of lives and putting a huge burden on the global economy …
Status report on COVID-19 vaccines development
A Kumar, WE Dowling, RG Román… - Current Infectious …, 2021 - Springer
Abstract Purpose of Review The emergence of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has affected lives of billions of individuals, globally. There is …
coronavirus-2 (SARS-CoV-2) has affected lives of billions of individuals, globally. There is …